The 25-year-old is now semi-conscious in hospital, unable to move or speak, and can only track things with her eyes ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

California’s drug crisis has only escalated, with so-called “compassionate solutions” like harm reduction and past policies that decriminalized hard drugs making things worse.

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to local medical professionals. "I think it could be a potentially ...

Addiction and mental health are deeply intertwined issues that affect millions of people in the United States. Understanding ...

It would take years, and hundreds of millions of dollars, to rebuild a bridge to the island and reopen the deteriorating ...

New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

A nthony James is the first to admit that for most of his adult life, he lived under the illusion that he was invincible.

Portland Treatment Center in Maine provides a wide range of services for those struggling with mental health and substance ...

The 26-year-old, whose real name is Litzy Lara Banuelos, entered the rehab center for her addiction to the dissociative anesthetic drug, which she was taking 5 to 6 grams of per day, her family ...

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.